Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04320511 · ClinicalTrials.gov registry record
Beaumont Quantitative Lung Function Imaging to Characterize Patients With SARS-COV 2
A clinical trial, sponsored by Corewell Health East.
- Terminated
- Registry status
- 15
- Enrollment target
NCT04320511: Clinical Trial study, sponsored by Corewell Health East.
NCT04320511 is a clinical trial that was terminated before completion, run by Corewell Health East. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04320511 was terminated before completion, sponsored by Corewell Health East.
- TERMINATED
- Registry status
- 15 participants
- Enrollment target
Study Summary
The goal of this study is to evaluate if CT (Computerized Tomography) can effectively and accurately predict disease progression in patients with SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2). You may be eligible if you have been diagnosed with SARS-CoV-2, are an inpatient at Beaumont Hospital-Royal Oak and meet eligibility criteria. After consent and determination of eligibility, enrolled patients will have a CT scanning session. After the CT scan, patients are followed for 30 days by reviewing their medical records and by phone after discharge from hospital.
Primary Outcome
Disease progression will be characterized as requiring mechanical ventilator support, non-invasive positive pressure ventilation, high flow nasal cannula or mortality within 30 days.CT-V and PBM scores will be calculated at a voxel level from inhalation-exhalation CT scan. Several CT-V pulmonary function metrics, including the volume of identified "cold spots" (areas with decreased ventilation and perfusion), total ventilation and perfusion and radiographic fibrosis score will be calculated to a
Interventions
- DEVICE CT-V
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2020-06-24 |
| Est. Completion | 2021-05-14 |
Why NCT04320511 stopped before completion
NCT04320511 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which CT-V is the first listed.
NCT04320511 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04320511 about?
NCT04320511 is a clinical study titled "Beaumont Quantitative Lung Function Imaging to Characterize Patients With SARS-COV 2". The goal of this study is to evaluate if CT (Computerized Tomography) can effectively and accurately predict disease progression in patients with SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2). You may be eligible if you have been diagnosed with SARS-CoV-2, are an inpatient at Beaumont...
What is the current status of trial NCT04320511?
This trial is currently terminated. The enrollment target is 15 participants. The study started on 2020-06-24. Estimated completion is 2021-05-14.
What interventions are being tested in trial NCT04320511?
The interventions under investigation include: CT-V (DEVICE).
Who is sponsoring clinical trial NCT04320511?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI